Zhou X, Berglund P, Zhao H, Liljeström P, Jondal M
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3009-13. doi: 10.1073/pnas.92.7.3009.
The Semliki Forest virus (SFV) expression system can be used to package recombinant RNA into infectious suicide particles. Such RNA encodes only the SFV replicase and the heterologous protein but no structural proteins of SFV, and it is thus deficient in productive replication. We demonstrate here that infection of C57BL/6 (H-2b) and BALB/c (H-2d) mice with recombinant SFV expressing the nucleoprotein (NP) of influenza virus (SFV-NP) resulted in efficient priming of influenza virus-specific CD8+ cytotoxic T-cell (CTL) responses. The generated CTLs lysed both homologous (A/PR/8/34) and heterologous (A/HK/68) influenza virus-infected, or peptide-coated, target cells to a similar degree as CTLs induced by wild-type influenza virus in a major histocompatibility complex class I-restricted fashion. As few as 100 infectious units of virus induced a strong CTL response. Induction of CTL by SFV-NP could also be achieved in CD4 gene-targeted mice, demonstrating the independence of the primary CTL response of CD4+ helper T cells. One immunization generated a CTL response that peaked after 1 week, and an additional booster injection generated a CTL memory, which was still detectable after 40 days. SFV-NP immunizations also generated high-titered IgG humoral responses that remained significant after several months. These results demonstrate that the recombinant SFV suicide system is highly efficient in antigen presentation and suggest that it may have a potential as a recombinant vaccine.
辛德毕斯病毒(SFV)表达系统可用于将重组RNA包装成感染性自杀颗粒。这种RNA仅编码SFV复制酶和异源蛋白,而不编码SFV的结构蛋白,因此在有效复制方面存在缺陷。我们在此证明,用表达流感病毒核蛋白(NP)的重组SFV(SFV-NP)感染C57BL/6(H-2b)和BALB/c(H-2d)小鼠,可有效启动流感病毒特异性CD8+细胞毒性T细胞(CTL)反应。所产生的CTL以主要组织相容性复合体I类限制的方式,对同源(A/PR/8/34)和异源(A/HK/68)流感病毒感染的或肽包被的靶细胞进行裂解,其程度与野生型流感病毒诱导的CTL相似。低至100个感染单位的病毒就能诱导强烈的CTL反应。在CD4基因靶向小鼠中也可通过SFV-NP诱导CTL,这表明CD4+辅助性T细胞对初始CTL反应具有独立性。一次免疫就能产生在1周后达到峰值的CTL反应,额外的加强注射可产生CTL记忆,在40天后仍可检测到。SFV-NP免疫还能产生高滴度的IgG体液反应,在几个月后仍很显著。这些结果表明,重组SFV自杀系统在抗原呈递方面非常高效,并表明它可能具有作为重组疫苗的潜力。